龙大美食(002726) - 2024 Q3 - 季度财报

Revenue and Profit - Revenue for Q3 2024 was CNY 2,969,961,598, a decrease of 12.12% compared to the same period last year[2] - Net profit attributable to shareholders for Q3 2024 was CNY 14,888,407, an increase of 161.61% year-on-year[2] - Net profit excluding non-recurring items for Q3 2024 was CNY 14,503,986, up 159.71% from the previous year[2] - Total operating revenue for the third quarter was CNY 8,014,093,619.26, a decrease of 20.5% compared to CNY 10,106,114,731.27 in the same period last year[10] - The company's net profit for the period was not explicitly stated, but the retained earnings showed a decrease from CNY -515,299,374.16 to CNY -442,258,344.99, indicating an improvement[9] - The net profit for Q3 2024 is CNY 78,459,055.58, a significant recovery from a net loss of CNY 698,305,622.33 in the same period last year[11] - The total operating profit for the quarter is CNY 77,789,039.35, compared to a loss of CNY 702,352,628.24 in Q3 2023[11] - The total comprehensive income for the quarter is CNY 78,459,055.58, compared to a comprehensive loss of CNY 698,305,622.33 in the same period last year[12] Cash Flow and Assets - Cash flow from operating activities for the year-to-date reached CNY 285,810,644, representing a 154.01% increase compared to the same period last year[5] - The company's cash and cash equivalents decreased from CNY 1,392,572,096.51 to CNY 936,716,720.77, a decline of approximately 32.7%[7] - The company experienced a decrease in cash and cash equivalents, ending the quarter with CNY 602,405,880.12, down from CNY 832,573,648.31 at the end of the previous year[14] - The net cash flow from investing activities was CNY -181,443,507, a decrease of 161.07% year-on-year, primarily due to reduced short-term investment recoveries[5] - The company reported a decrease in cash flow from investing activities, with a net outflow of CNY 181,443,506.54 compared to an inflow of CNY 297,100,980.79 in the previous year[14] Assets and Liabilities - Total assets as of September 30, 2024, were CNY 5,972,864,042, a decrease of 5.46% from the end of the previous year[2] - The total assets decreased from CNY 6,317,538,408.46 to CNY 5,972,864,041.76, a decline of about 5.5%[9] - Total current assets decreased from CNY 2,957,618,541.03 to CNY 2,633,612,808.05, a decline of about 10.9%[7] - The total liabilities decreased from CNY 4,660,577,593.02 to CNY 4,237,443,126.04, a decline of about 9%[9] - Current liabilities decreased significantly from CNY 3,343,091,858.70 to CNY 2,908,640,469.36, a reduction of approximately 13%[9] Shareholder Information - Shareholders' equity attributable to the parent company increased to CNY 1,555,023,681, up 4.93% from the end of the previous year[2] - The total number of common shareholders at the end of the reporting period is 29,126[6] - The largest shareholder, Lanyun Development Holdings Group Co., Ltd., holds 27.23% of the shares, totaling 293,885,800 shares[6] - The company has no changes in the participation of major shareholders in the securities lending business compared to the previous period[7] - There are no preferred shareholders or changes in the number of preferred shareholders reported[7] Operating Expenses and Costs - The company experienced a 40.73% increase in operating expenses, totaling CNY 6,864,412, attributed to material losses[5] - Total operating costs amounted to CNY 7,969,780,736.86, down 23.9% from CNY 10,459,170,677.73 year-over-year[10] - The total operating expenses for the quarter were CNY 6,864,412.05, an increase from CNY 4,877,809.54 in Q3 2023[11] - The company reported a decrease in research and development expenses from CNY 7,124,256.62 to CNY 5,415,302.61, a reduction of approximately 24%[10] Other Financial Metrics - The weighted average return on equity for the year-to-date was 5.45%, an increase of 28.83% compared to the same period last year[2] - The basic earnings per share for Q3 2024 is CNY 0.0677, compared to a loss per share of CNY 0.6009 in Q3 2023[12] - The company incurred asset impairment losses of CNY 29,105,088.31, a significant improvement from CNY 184,782,957.11 in the previous year[11] - The company reported a total of CNY 51,483,940.80 in other receivables, up from CNY 44,828,566.76, an increase of about 14.7%[7] Production and Investment - The company reported a significant increase in production biological assets, which rose by 411.61% to CNY 25,386,775 due to the purchase of assets[5] - Fixed assets increased to CNY 1,841,400,574.33 from CNY 1,692,939,156.89, reflecting a growth of 8.8%[8]